Kalyan Singh Cancer Institute and Miimansa AI Sign MoU to Advance AI-Driven Cancer Research and Care
Kalyan Singh Cancer Institute and Miimansa AI Sign MoU to Advance AI-Driven Cancer Research and Care

April 8, 2026


Today, April 8, 2026 an MoU has been singed and exchanged between Kalyan Singh Super
Speciality Cancer Institute, Lucknow and Miimansa AI Sign MoU to conduct the joint research
activities in oncology and its allied sciences through the application of Artificial Intelligence model.
The MoU was signed by Prof. M.L.B. Bhatt, Director of KSSSCI, and Dr. Vibhu Aggrwal, Founder of
Miimansa AI, in the presence of Medical Superintendent Dr. Varun Vijay and Assistant Professor Dr.
Abhinav Tiwari.
The primary objective of this collaboration is to develop an advance AI-driven clinical research, digital
health production validation and mental health awareness programs and also to create innovative and
computational models for early cancer detection. Through this partnership, both institutions aim to
leverage technical expertise and intellectual property to translate cancer research into real-world clinical
services and public health benefits, marking a revolutionary step in future cancer care through AI based model